A randomized double-blind parallel placebo trial to evaluate the efficacy and safety of sulodexide on diabetes with marcoalbuminuria.
Phase of Trial: Phase IV
Latest Information Update: 24 Apr 2016
At a glance
- Drugs Sulodexide (Primary)
- Indications Diabetic nephropathies; Proteinuria
- Focus Therapeutic Use
- 24 Jul 2014 Status changed from not yet recruiting to completed as reported by Chinese Clinical Trial Register record.
- 21 May 2012 Planned end date changed from 1 Mar 2011 to 1 Dec 2011 as reported by Chinese Clinical Trial Register record.
- 31 Oct 2009 New trial record